GlaxoSmithKline PLC Director/PDMR Shareholding (9275Q)
22 Febrero 2019 - 11:30AM
UK Regulatory
TIDMGSK
RNS Number : 9275Q
GlaxoSmithKline PLC
22 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
========================================================================
a) Name Mr S Dingemans
=== ======================== ==============================================
b) Position/status Chief Financial Officer
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB000
=== ======================== ==============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the exercise of options granted on 29 October
2015 at the option price of GBP10.13 per
Ordinary Share under the Company's ShareSave
Plan.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP10.13 266
----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2019-02-22
=== ======================== ==============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
========================================================================
a) Name Mr N Hirons
=== ======================== ==============================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ==============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the exercise of options granted on 29 October
2015 at the option price of GBP10.13 per
Ordinary Share under the Company's ShareSave
Plan.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP10.13 888
----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2019-02-22
=== ======================== ==============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ==============================================
1. Details of PDMR/person closely associated with them
('PCA')
========================================================================
a) Name Mrs V Whyte
=== ======================== ==============================================
b) Position/status Company Secretary
=== ======================== ==============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ==============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ==============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ==============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ========================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ==============================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the exercise of options granted on 29 October
2015 at the option price of GBP10.13 per
Ordinary Share under the Company's ShareSave
Plan.
=== ======================== ==============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP10.13 888
----------
=== ======================== ==============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ==============================================
e) Date of the transaction 2019-02-22
=== ======================== ==============================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ==============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDLLFLKLFLBBQ
(END) Dow Jones Newswires
February 22, 2019 12:30 ET (17:30 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024